Pulmonary hypoplasia is a condition that affects the development of the lungs and pulmonary alveoli in fetuses and newborns, potentially resulting in life-threatening complications. Diagnosis can be aided by non-invasive tests such as MRI and CT scans, and treatment may involve corrective surgery and assisted ventilation. Survivors may require ongoing medical management due to increased risk of chronic lung disease and other issues.
Pulmonary hypoplasia (P-Hyp) is a developmental anomaly affecting fetuses and newborns, resulting in malformation of the lungs and pulmonary alveoli, the small air sacs in the lungs where oxygen and carbon dioxide are exchanged. A diagnosis of this condition might be made before or soon after a baby is born. In cases where pulmonary hypoplasia develops and not enough alveoli form, a child’s lungs will not be able to function at the same level as a child who does not have this condition. Pulmonary hypoplasia could also develop in combination with other congenital medical conditions. While this health abnormality has been indicated to result in the premature death of infants or children, depending on the severity of the malformation and the treatment options available, it could also be a non-life-threatening condition.
Factors that may indicate the presence of pulmonary hypoplasia could include shortened airways, decreased lung volume, and decreased lung weight. There are several types of non-invasive tests that can be done to aid in the diagnosis of this condition. Magnetic resonance imaging (MRI) tests might be used to evaluate fetal volume before birth, and a computed tomography (CT) scan might be used after the baby is born. Also, by calculating fetal lung volume, a physician may be able to access the possibility of lung hypoplasia present. To predict the development of this condition in cases where the fetus is extremely small, a combination of ultrasound and MRI can be used to determine the approximate fetal weight.
There are other health conditions that may be present in children who have pulmonary hypoplasia, such as heart malformations, diaphragmatic hernias, or gastrointestinal abnormalities. Other conditions that may be present in these infants include chest or abdominal masses, musculoskeletal malformations, and renal complications. With modern medical tests, it is possible to accurately identify most of the associated irregularities that could contribute to the development of this condition.
A child who tests positive for pulmonary hypoplasia will need to be closely monitored after diagnosis. If other health complications are present, corrective surgery may be required. Additional treatments may include intubation and assisted ventilation.
In addition, the baby’s blood gases, potenz hydrogen (pH) levels, oxygen saturation, and other bodily functions are likely to be observed. Survivors of pulmonary hypoplasia are at increased risk of developing chronic lung disease and may have problems associated with cardiac function, nutrition, growth and development. For this reason, careful management of any additional medical conditions and ongoing physician supervision throughout the patient’s life will most likely be required.
Protect your devices with Threat Protection by NordVPN
